Your doctor will likely treat your cancer using drugs that target EGFR, although you may have surgery or chemotherapy, too. Your doctor will help you decide the best way to treat your NSCLC based ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

In addition, Burns said that patients can continue on an EGFR inhibitor – either lazertinib (Lazcluze) plus amivantamab or ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...

In a breakthrough study, researchers from the National University of Singapore (NUS) have developed a new way to deliver ...

Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.

Sunvozertinib has shown promising results in patients with non–small cell lung cancer with an EGFR exon 20 insertion mutation ...

The team tested their new method to screen drugs that can target the epidermal growth factor receptor (EGFR), a molecule ...

In contrast to the anti-EGFR MAb, anti-EGFR small molecule tyrosine kinase inhibitors do not lead to receptor internalization. Furthermore, these drugs could be either relatively selective and ...

One investigation discussed during the call involves sales reps in China allegedly changing genetic testing results to secure reimbursement for Tagrisso.

Due to the frequent mutations that enable drug resistance, lung cancer remains particularly ... The current standard ...